Leadership Overview
Boston Scientific has 10 executives leading key functions including finance, technology, medical affairs, and regional operations.
Driven by innovation, Boston Scientific is dedicated to transforming lives through groundbreaking medical technologies, focusing on improving patient outcomes and clinical efficiency across diverse interventional specialties.
Driven by innovation, Boston Scientific is dedicated to transforming lives through groundbreaking medical technologies, focusing on improving patient outcomes and clinical efficiency across diverse interventional specialties.
Leadership Roles at Boston Scientific
Daniel Brennan - Executive Vice President & Chief Financial Officer
Daniel Brennan, the Executive Vice President & Chief Financial Officer at Boston Scientific, directs all financial operations and strategic fiscal planning for the global medical device company. Brennan oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health across the MedSurg and Cardiovascular segments. This leadership role involves managing capital allocation, investor relations, and driving financial strategies that support the development and commercialization of minimally invasive technologies. Brennan's oversight extends to optimizing financial performance to enable the company's mission of improving patient outcomes worldwide. The financial direction provided by Daniel Brennan is critical for sustaining Boston Scientific's market position and facilitating its ongoing investment in advanced medical solutions.
Bernardo Del - Director, Finance (Country & Chief Financial Officer (Mexico)
Bernardo Del, the Director, Finance (Country & Chief Financial Officer (Mexico) at Boston Scientific, manages the financial operations and strategic fiscal direction for the company within Mexico. Del oversees all aspects of financial planning, budgeting, and reporting specific to the Mexican market, ensuring alignment with global financial objectives. This role is crucial for supporting the commercialization of Boston Scientific's medical devices within the region, adapting global strategies to local market dynamics. Bernardo Del's financial leadership ensures the efficient allocation of resources and drives profitability for the company's operations in Mexico. The financial acumen provided by Del is vital for navigating the complexities of the Mexican healthcare landscape and contributing to the company's overall growth.
James Cassidy - President, Scientific Neuromodulation (Boston)
James Cassidy, the President, Scientific Neuromodulation (Boston) at Boston Scientific, leads the strategic direction and operational execution for the neuromodulation business unit based in Boston. Cassidy drives innovation and market growth for advanced neuromodulation technologies, overseeing product development, commercial strategies, and business operations. This executive role involves fostering a culture of scientific excellence and ensuring the successful delivery of solutions that address critical patient needs. The leadership provided by James Cassidy is pivotal in advancing Boston Scientific's position in the neuromodulation market. Cassidy's focus on scientific advancement and market expansion directly supports the company's commitment to transforming lives through cutting-edge medical devices.
Rafael Carbunaru - Chief Technology Officer, Neuromodulation
Rafael Carbunaru, the Chief Technology Officer, Neuromodulation at Boston Scientific, architects the technological vision and innovation pipeline for the neuromodulation division. Carbunaru guides research and development efforts, focusing on creating advanced solutions for conditions treated by this specialty. This involves leading teams in the design and engineering of cutting-edge devices, ensuring technological superiority and market differentiation. The strategic direction set by Rafael Carbunaru is essential for advancing the company's portfolio of neuromodulation technologies, directly impacting the development of new catheters, implants, and related systems. Carbunaru's expertise drives the technological evolution necessary to enhance patient care and clinical efficiency within this critical area of medicine.
Chan Ella - Vascular Strategy Lead Chief of Staff
Chan Ella, the Vascular Strategy Lead Chief of Staff at Boston Scientific, drives strategic initiatives and operational alignment within the vascular division. Ella supports the leadership team by coordinating cross-functional efforts, facilitating communication, and ensuring the execution of key strategic priorities related to vascular technologies. This role involves translating high-level strategy into actionable plans, optimizing workflows, and enhancing overall business performance. The strategic guidance provided by Chan Ella is instrumental in advancing Boston Scientific's market position in vascular interventions. Ella's focus on operational excellence and strategic planning directly supports the development and commercialization of advanced solutions like stents and catheters, contributing to improved patient outcomes.
Deniz Özgünay - Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets
Deniz Özgünay, the Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets at Boston Scientific, spearheads initiatives to enhance commercial performance and strategic execution across emerging markets. Özgünay focuses on optimizing sales strategies, improving market penetration, and driving business growth in these key regions. This leadership position involves analyzing market trends, identifying opportunities, and implementing best practices to elevate commercial effectiveness. The strategic support provided by Deniz Özgünay is critical for expanding Boston Scientific's reach and impact in diverse global markets. Özgünay's work directly contributes to the successful commercialization of the company's advanced medical technologies, supporting improved patient care and clinical efficiency worldwide.
Joseph Bockover - Manager, Area Business & Strategy Chief of Staff
Joseph Bockover, the Manager, Area Business & Strategy Chief of Staff at Boston Scientific, directs strategic planning and business operations within designated areas. Bockover supports executive leadership by ensuring strategic initiatives are effectively implemented and operational goals are met. This involves analyzing business performance, identifying areas for improvement, and coordinating cross-functional teams to drive efficiency and growth. The strategic oversight provided by Joseph Bockover is essential for optimizing Boston Scientific's business operations and market presence. Bockover's role in strategy development and execution directly supports the company's mission to provide advanced medical technologies that improve patient outcomes globally.
Brian Dunkin - Chief Medical Officer
Brian Dunkin, the Chief Medical Officer at Boston Scientific, provides critical medical and clinical insights to guide the company's product development and strategic direction. Dunkin oversees clinical affairs, ensuring that all technologies and solutions align with the highest standards of patient care and medical efficacy. This leadership role involves collaborating with R&D, marketing, and sales teams to integrate clinical perspectives into product design and commercialization strategies. The medical expertise provided by Brian Dunkin is fundamental to Boston Scientific's commitment to improving patient outcomes and advancing minimally invasive technologies. Dunkin's guidance ensures the company's innovations effectively address unmet clinical needs worldwide.
Scott Kreiner - Chief Medical Officer, Neuromodulation
Scott Kreiner, the Chief Medical Officer, Neuromodulation at Boston Scientific, leads the clinical strategy and medical affairs for the neuromodulation division. Kreiner ensures that the development and deployment of neuromodulation technologies are grounded in robust clinical evidence and patient-centric principles. This involves guiding clinical trials, interpreting medical data, and advising on the therapeutic applications of the division's advanced devices. The medical leadership provided by Scott Kreiner is crucial for advancing treatments in areas such as pain management and neurological disorders. Kreiner's focus on clinical excellence directly supports Boston Scientific's mission to transform lives through innovative medical solutions in this specialized field.
Robert Seat - Regional Executive
Robert Seat, the Regional Executive at Boston Scientific, directs and oversees the company's operations and strategic initiatives within a specific geographic region. Seat is responsible for driving business growth, managing regional sales teams, and ensuring the successful commercialization of Boston Scientific's medical devices across the assigned territory. This leadership role involves adapting global strategies to local market conditions, fostering strong relationships with healthcare providers, and optimizing operational efficiency. The regional leadership provided by Robert Seat is vital for expanding Boston Scientific's market presence and impact. Seat's focus on regional performance directly contributes to the company's overall mission of improving patient outcomes through advanced medical technologies.
Explore Leadership Teams in Manufacturing
Advita Ortho, headquartered in Gainesville, Florida, is a global medical device company dedicated to advancing patient lives through innovative orthopedic solutions. Officially launched in November 2025, the company delivers high-quality orthopedic implants and a comprehensive suite of integrated surgical technologies powered by data, artificial intelligence, and machine learning. Advita Ortho owns and distributes established product lines including the Equinoxe Shoulder, Vantage Ankle, Alteon Hip, Truliant Knee, Newton balancing technology, and GPS navigation systems, among others. The company's portfolio creates an ecosystem designed to enhance surgical decision-making in the operating room while driving efficiency for healthcare systems. Led by industry veterans and backed by investment firms including Strategic Value Partners, Stellex Capital Management, and Greywolf Capital Management, Advita Ortho positions itself as a trusted partner to orthopedic surgeons worldwide, providing tools and technologies designed to improve patient outcomes and quality of life.
Company Leadership
Orthofix is a global medical technology company based in Lewisville, Texas, focused on developing solutions for the treatment of musculoskeletal conditions. The company provides a broad range of medical technologies designed to improve patient outcomes, including spinal hardware, bone growth therapies, specialized limb reconstruction solutions, biologics, and enabling technologies, serving patients worldwide.
Company Leadership MC
CB
Founded in 1945, Micro Stamping is a full-service contract manufacturing company that specializes in medical devices such as, titanium and stainless steel ligation clips and implant devices. Micro Stamping is located in New Jersey.
Company Leadership LW
DT
ED
DB
AxoGen is a medical device manufacturing company founded in 2002 that specializes in developing and producing surgical solutions for peripheral nerve injuries. The company offers a comprehensive portfolio of products including nerve grafts, connectors, and protectors designed to facilitate nerve repair and regeneration. AxoGen's innovative solutions include the Avance Nerve Graft for bridging severed nerves, AxoGuard Nerve Connector for tensionless nerve repair, and AxoGuard Nerve Protector for protecting injured peripheral nerves. Additionally, the company provides diagnostic and measurement tools such as the AcroVal neurosensory testing system and AxoTouch discriminator. AxoGen distributes its products to hospitals, surgery centers, and military medical facilities across North America, Europe, and other international markets, serving the needs of surgeons and patients in peripheral nerve repair procedures.
Company Leadership
LH
Frequently Asked Questions Regarding Boston Scientific Top Executives and Leadership Team
Unlock more people and company data
